The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Latest News

FDA Approves First Generic of Rivaroxaban (Xarelto) for CAD, PAD | Image Credit: US Food and Drug Administration
FDA Approves First Generic of Rivaroxaban (Xarelto) for CAD, PAD

March 5th 2025

The agency approved the first generic of the anticoagulant rivaroxaban to lower the risk of cardiovascular and thromboembolic events in adults with CAD and PAD.

FDA Approves Tenecteplase (TNKase) for Acute Ischemic Stroke | Image Credit: US Food and Drug Administration
FDA Approves Tenecteplase (TNKase) for Acute Ischemic Stroke

March 4th 2025

Cardiology Month in Review: February 2025 | Image Credit: HCPLive
Cardiology Month in Review: February 2025

March 3rd 2025

FDA News Month in Review: January 2025 | Image Credit: HCPLive
FDA News Month in Review: February 2025

February 28th 2025

Deepak Bhatt, MD, MPH, MBA | Credit: Mount Sinai
Study Finds Icosapent Ethyl Can Reduce Cardiovascular Risk, Even in Well-Controlled LDL-C

February 28th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.